ARK Genomic Revolution ETF vs AXT Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.7, while AXT Inc trades at $78.7 (market cap $4.83B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, AXT Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | AXTI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $140.83 |
52-Week Low | $24.02 | $2.05 |
Market Cap | — | $4.83B |
Enterprise Value | — | $4.50B |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →